Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PrimeBioMed

PrimeBioMed?uq=oeHSfu7P
2013 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Provider of an innovative diagnostic systems intended to develop antibodies for cancer diagnosis. The company's systems includes development and manufacture of antibodies, enabling clients to treat cancer easily.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Naychny proezd 20
  • b. 3
  • Moscow, 117246
  • Russia

+7 8 (000) 000-00-00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PrimeBioMed’s full profile, request a free trial.

PrimeBioMed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 25-Sep-2017 00.000 Completed Generating Revenue
2. Early Stage VC 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2013 $2.02M $2.02M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

PrimeBioMed Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Russian Venture Company Fund of Funds Minority 000 0000 000000 0
Skolkovo Foundation Limited Partner Minority 000 0000 000000 0

PrimeBioMed Executive Team (3)

Name Title Board
Seat
Contact
Info
Alexey Grachev Ph.D Co-Founder & Chief Executive Officer
Olga Lopaeva Co-Founder
Yuliya Kzhyshkovska Co-Founder